Netherlands· NL-a7db6aaf0b93
Fosinoprilnatrium Sandoz 10, tabletten 10 mg
A fosinopril product containing fosinopril natrium, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Fosinopril is registered in 12 of 19 countries.
Countries holding a registration under ATC C09AA09 (fosinopril), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Fosinopril · ATC C09AA09
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fosinopril costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.16 in France to $0.25 in Spain — a ×1.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fosinopril · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- ES Spain$0.25
- IT Italy$0.23
- FR France$0.16
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FOSINOPRIL NATRIUM
- Manufacturer
- Sandoz B.V.
- Country
- Netherlands (NL)
- ATC code
- C09AA09
- ATC class
- Fosinopril
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- August 25, 2026
Packs & prices · 1
- cbg_meb_id32258
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
296 interactions on record for fosinopril.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fosinopril · interactions on record
296 records
- 11 severe
- 165 moderate
- 17 minor
- 53 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
50 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fosinopril in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFosinopril 10mg tabletsMedihealth (Northern) Ltd
- United StatesFosinopril sodiumBryant Ranch Prepack
- FranceFOSINOPRIL ARROW GENERIQUES 10 mg, comprimé sécableARROW GENERIQUES
- CanadaAPO-FOSINOPRILAPOTEX INC
- SwedenFosinopril Actavis 10 mg TablettActavis Group PTC ehf.
- FinlandMonoprilBristol-Myers Squibb Ab
- ItalyELITENBAUSCH HEALTH IRELAND LIMITED
- SpainFOSINOPRIL AUROBINDO 20 mg COMPRIMIDOS EFGLaboratorios Aurobindo S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Fosinopril Actavis, Fositens
- Belgium · Fosinil
- Bulgaria · Моноприл
- Czechia · Monopril
- Germany · Fosinorm
- Estonia · Fosinopril Actavis
- Spain · Fosinopril Aurovitas, Fositens
- France · Fosinopril Arrow Generiques, Fosinopril Arrow Lab
- United Kingdom (Northern Ireland) · Fosinopril Sodium Milpharm
- Greece · Monopril
- Hungary · Monopril
- Italy · Eliten, Fosinopril Aurobindo
- Luxembourg · Fosinil
- Latvia · Fosinopril Actavis
- Portugal · Fosinopril Aurovitas, Fosinopril Generis
- Romania · Monopril
- Slovenia · Monopril
- Slovakia · Monopril
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/37aabd1d-f342-45db-b7d3-b40b39609dad GET /v1/drugs/37aabd1d-f342-45db-b7d3-b40b39609dad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h32258_smpc.pdf",
"strength": null,
"atc_label": "Fosinopril",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg32258",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROLDIBEHENAAT",
"LACTOSE 1-WATER",
"STARCH, PREGELATINISED (NOT FROM WHEAT STARCH)"
],
"substances": [
"FOSINOPRIL NATRIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h32258.pdf",
"authorised_at": "2005/03/10",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "32258",
"additional_monitoring": "N"
}See everything about fosinopril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.